Department: Barts Cancer Institute
Salary: £33,615 - £37,411 per annum (Grade 4)
Location: Charterhouse Square
Date posted: 06-Dec-2018
Closing date: 28-Feb-2019
Applications are sought for a postdoctoral research assistant to undertake research into how the cytoskeleton of cancer cells impact the tumour microenvironment. The successful applicant will have a PhD in a relevant biological subject and significant research laboratory experience in tumour microenvironment. The research will be based in the Centre for Cancer and Inflammation, Barts Cancer Institute, within the Barts and The London School of Medicine and Dentistry, Queen Mary, University of London.
Essential requirements for this post include cancer biology experience and an appropriate publication record. Experience with microscopy and cell signalling would be an advantage. A demonstrated ability to communicate well, work within a team and maintain good laboratory records is also essential.
The post is full time for 2 years in the first instance. Starting salary will be in the range £33,615 to £37,411 per annum, inclusive of London Allowance. Benefits include 30 days annual leave, pension scheme and an interest free season ticket loan.
The Barts Cancer Institute requires applicants to provide all certificates at interview to confirm their qualifications (specified in the Job Description).
Candidates must be able to demonstrate their eligibility to work in the UK in accordance with the Immigration, Asylum and Nationality Act 2006. Where required this may include entry clearance or continued leave to remain under the Points Based Immigration Scheme.
Informal enquiries about this post, including arrangements to visit the Institute/Centre, can be made to Dr Victoria Sanz-Moreno, tel: 020 7 882 6711 or email email@example.com
Details about Barts Cancer Institute can be found at www.bci.qmul.ac.uk
To apply, please visit the Human Resources website on http://www.jobs.qmul.ac.uk and search for reference QMUL17007.
The Closing date is 28th February 2019 and interviews are likely to be held in early March.
Valuing Diversity & Committed to Equality